| 多西紫杉醇联合替吉奥治疗蒽环类耐药晚期三阴乳腺癌疗效观察 |
| |
| 引用本文： | 谢彦,陈冬波,谢晓东.多西紫杉醇联合替吉奥治疗蒽环类耐药晚期三阴乳腺癌疗效观察[J].肿瘤基础与临床,2013,26(4):298-300. |
| |
| 作者姓名： | 谢彦 陈冬波 谢晓东 |
| |
| 作者单位： | 1. 徐州医学院第二附属医院肿瘤内科,江苏徐州,221000
2. 徐州市肿瘤医院肿瘤内科,江苏徐州,221005 |
| |
| 摘 要： | 目的观察多西紫杉醇联合替吉奥治疗蒽环类耐药晚期三阴乳腺癌(TNBC)的临床疗效和毒副反应。方法采用多西紫杉醇联合替吉奥治疗46例蒽环类耐药的晚期TNBC患者,3周为1周期,治疗2周期后评价疗效及毒副反应。结果 46例患者中,CR 1例,PR 15例,SD 18例,PD 12例,有效率34.8%,疾病控制率73.9%。主要毒副反应为骨髓抑制和胃肠道反应,无化疗相关死亡患者。结论多西紫杉醇联合替吉奥治疗蒽环类耐药晚期TNBC有效,毒副反应轻,患者耐受性好。
|
| 关 键 词： | 多西紫杉醇 替吉奥 蒽环类药物 晚期三阴乳腺癌 |
Docetaxel Combined with S-1 in the Treatment of Anthracycline-resistant Advanced Triple-negtive Breast Cancer |
| |
| Xie Yan
,
Chen Dongbo
,
Xie Xiaodong.Docetaxel Combined with S-1 in the Treatment of Anthracycline-resistant Advanced Triple-negtive Breast Cancer[J].journal of basic and clinical oncology,2013,26(4):298-300. |
| |
| Authors: | Xie Yan Chen Dongbo Xie Xiaodong |
| |
| Institution: | 1.Department of Oncology,the Second Affiliated Hospital of Xuzhou Medical School,Xuzhou 221000,China; 2.Department of Oncology,Xuzhou Tumor Hospital,Xuzhou 221005,China) |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
